Cargando…
A potentially effective drug for patients with recurrent glioma: sermorelin
BACKGROUND: Treatment insensitivity is the main cause of glioma. This study was designed to screen out effective drugs for recurrent gliomas based on the transcriptomics data. METHODS: A total of 1,018 glioma patients with transcriptome sequencing data and clinical data were included in this study....
Autores principales: | Chang, Yuanhao, Huang, Ruoyu, Zhai, You, Huang, Lijie, Feng, Yuemei, Wang, Di, Chai, Ruichao, Zhang, Wei, Hu, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033379/ https://www.ncbi.nlm.nih.gov/pubmed/33842627 http://dx.doi.org/10.21037/atm-20-6561 |
Ejemplares similares
-
Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020) -
Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?
por: Walker, Richard F
Publicado: (2006) -
Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
por: Zhai, You, et al.
Publicado: (2020) -
A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
por: Li, Guanzhang, et al.
Publicado: (2020) -
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020)